Increased Hematopoietic Stem Cell Mobilization
- Name
- Increased Hematopoietic Stem Cell Mobilization
- Accession Number
- DBCAT004418
- Description
Not Available
- Drugs
Drug Drug Description Plerixafor A CXCR4 antagonist used in combination with granulocyte-colony stimulating factor to mobilize hematopoietic stem cells to the peripheral blood for collection and autologous transplantation in patients with non-Hodgkin’s lymphoma and multiple myeloma. - Drugs & Drug Targets
Drug Target Type Plerixafor C-X-C chemokine receptor type 4 target